Source: Pharmabiz

Teewinot Life Sciences: Teewinot receives Canadian patent for biosynthetic methods for production of cannabinoids

Teewinot Life Sciences Corporation, a global leader in the production of cannabinoids for use in the pharmaceutical and nutraceutical markets, and its wholly owned Irish subsidiary Teewinot Technologies, Ltd, announced

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Michael A. Luther's photo - President & CEO of Teewinot Life Sciences

President & CEO

Michael A. Luther

CEO Approval Rating

82/100

Read more